Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France;Distribution des sérotypes de pneumocoques responsables des pleuropneumopathies de l'enfant en France

Archives de Pediatrie

Volumn 14, Issue 3, 2007, Pages 239-243

  Bekri, H ^a   Cohen, R ^b   Varon, E ^c   Madhi, F ^b   Gire, R ^a   Guillot, F ^a   Delacourt, C ^b  

^a Centre Hospitalier Intercommunal de Villeneuve Saint Georges   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Child; Empyema; pleural; Pleural effusion; Pneumococcus; Vaccination

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BLOOD GROUP TYPING; CLINICAL ARTICLE; FEMALE; FRANCE; HUMAN; INFANT; MALE; PLEURA EMPYEMA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; ADOLESCENT; CHILD; CLASSIFICATION; MICROBIOLOGY; SEROTYPING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMPYEMA, PLEURAL; FEMALE; FRANCE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 33847621280     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.12.010     Document Type: Article

References (15)

1. Balfour-Lynn I.M., Abrahamson E., Cohen G., et al. BTS guidelines for the management of pleural infection in children. Thorax 60 Suppl 1 (2005) i1-i21
2. Weil-Olivier C., Levy C., Marguet C., et al. Enquête rétrospective multicentrique sur les pleuropneumopathies infectieuses de l'enfant en France. Arch. Pediatr. 12 (2005) 823-826
3. ®. Médecine et Enfance 2 (2005) 299-302
4. Kaplan S.L., Mason Jr. E.O., Wald E.R., et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United-States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113 (2004) 443-449
5. Tan T.Q., Mason Jr. E.O., Wald E.R., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110 (2002) 1-6
6. Eastham K.M., Freeman R., Kearns A.M., et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59 (2004) 522-525
7. Byington C.L., Spencer L.Y., Johnson T.A., et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin. Infect. Dis. 34 (2002) 434-440
8. Hausdorff W.P., Bryant J., Kloek C., et al. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin. Infect. Dis. 30 (2000) 122-140
9. Geslin P. Centre national de référence du pneumocoque : rapport d'activité 1997.
10. Observatoires régionaux du pneumocoque. Surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France en 1999. BEH 33 (2001) 155-160
11. Jakobsen H., Sigurdsson V.D., Sigurdardottir S., et al. Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model. Infect. Immun. 71 (2003) 2956-2959
12. Whitney C.G., Farley M.M., Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348 (2003) 1737-1746
13. Kyaw M.H., Lynfield R., Schaffner W., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354 (2006) 1455-1463
14. Schultz K.D., Fan L.L., Pinsky J., et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113 (2004) 1735-1740
15. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19 (2000) 187-195